FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1968652295> ?p ?o ?g. }

• W1968652295 endingPage "49" @default.
• W1968652295 startingPage "45" @default.
• W1968652295 abstract "Hydroxyurea is one of the most successfully used therapies for sickle cell disease. Results of many clinical trials point to hydroxyurea administration for patients with frequent painful crises and acute chest syndrome. Priapism is one of the complications that could be prevented by hydroxyurea, but there are few reports demonstrating the results. Since November 1993, hydroxyurea has been used in our clinic for preventing priapism in patients with stuttering or major attacks who are still capable of achieving intercourse on demand. Five patients were enrolled in the study, and 4 cases benefited by this treatment. After the initial treatment for the acute attack, all five patients developed stuttering priapism. Hydroxyurea was then introduced at the initial dose of 10 mg/kg, and as the hydroxyurea dosage increased, the number or length of priapism episodes decreased. One to two months after the maximal dose (20–35 mg/kg) was introduced, the episodes disappeared. In two patients, we were forced to administer over 30 mg hydroxyurea/kg to abort the episodes, and, in another patient, 25 mg/kg was necessary. All patients present normal sexual activity. Hydroxyurea was discontinued in two patients, but stuttering priapism reappeared. Hydroxyurea was then re-introduced, and priapism disappeared. One patient, using 20 mg hydroxyurea/kg, had a 6-year remission of priapism after hydroxyurea administration; however, he experienced stuttering priapism, 1 month before a major attack, that progressed to impotence. During that month, he did not seek medical attention. In conclusion, the data here presented suggests that hydroxyurea may prevent priapism attacks in sickle cell disease, probably at higher doses than usually prescribed for painful crisis prevention. Am. J. Hematol. 77:45–49, 2004. © 2004 Wiley-Liss, Inc." @default.
• W1968652295 created "2016-06-24" @default.
• W1968652295 creator A5008745844 @default.
• W1968652295 creator A5029695191 @default.
• W1968652295 creator A5032144125 @default.
• W1968652295 creator A5032989942 @default.
• W1968652295 creator A5039927875 @default.
• W1968652295 creator A5067713063 @default.
• W1968652295 creator A5083658192 @default.
• W1968652295 date "2004-01-01" @default.
• W1968652295 modified "2023-10-06" @default.
• W1968652295 title "Follow-up of sickle cell disease patients with priapism treated by hydroxyurea" @default.
• W1968652295 cites W1559833729 @default.
• W1968652295 cites W1601711829 @default.
• W1968652295 cites W170541499 @default.
• W1968652295 cites W1835121324 @default.
• W1968652295 cites W1972716918 @default.
• W1968652295 cites W1981818777 @default.
• W1968652295 cites W2000770399 @default.
• W1968652295 cites W2015337008 @default.
• W1968652295 cites W2027446314 @default.
• W1968652295 cites W2027789486 @default.
• W1968652295 cites W2030040458 @default.
• W1968652295 cites W2039806480 @default.
• W1968652295 cites W2045392613 @default.
• W1968652295 cites W2046500825 @default.
• W1968652295 cites W2049354191 @default.
• W1968652295 cites W2056291788 @default.
• W1968652295 cites W2061972670 @default.
• W1968652295 cites W2062117176 @default.
• W1968652295 cites W2070434673 @default.
• W1968652295 cites W2075706580 @default.
• W1968652295 cites W2076832075 @default.
• W1968652295 cites W2126233568 @default.
• W1968652295 cites W2137322303 @default.
• W1968652295 cites W2137742501 @default.
• W1968652295 cites W2145724610 @default.
• W1968652295 cites W2159085792 @default.
• W1968652295 cites W2258655905 @default.
• W1968652295 cites W2313541759 @default.
• W1968652295 cites W2319125068 @default.
• W1968652295 cites W29610599 @default.
• W1968652295 cites W4242029354 @default.
• W1968652295 cites W4253130889 @default.
• W1968652295 cites W4293765499 @default.
• W1968652295 cites W7055056 @default.
• W1968652295 doi "https://doi.org/10.1002/ajh.20142" @default.
• W1968652295 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15307105" @default.
• W1968652295 hasPublicationYear "2004" @default.
• W1968652295 type Work @default.
• W1968652295 sameAs 1968652295 @default.
• W1968652295 citedByCount "49" @default.
• W1968652295 countsByYear W19686522952012 @default.
• W1968652295 countsByYear W19686522952013 @default.
• W1968652295 countsByYear W19686522952014 @default.
• W1968652295 countsByYear W19686522952015 @default.
• W1968652295 countsByYear W19686522952016 @default.
• W1968652295 countsByYear W19686522952017 @default.
• W1968652295 countsByYear W19686522952018 @default.
• W1968652295 countsByYear W19686522952020 @default.
• W1968652295 countsByYear W19686522952021 @default.
• W1968652295 countsByYear W19686522952022 @default.
• W1968652295 countsByYear W19686522952023 @default.
• W1968652295 crossrefType "journal-article" @default.
• W1968652295 hasAuthorship W1968652295A5008745844 @default.
• W1968652295 hasAuthorship W1968652295A5029695191 @default.
• W1968652295 hasAuthorship W1968652295A5032144125 @default.
• W1968652295 hasAuthorship W1968652295A5032989942 @default.
• W1968652295 hasAuthorship W1968652295A5039927875 @default.
• W1968652295 hasAuthorship W1968652295A5067713063 @default.
• W1968652295 hasAuthorship W1968652295A5083658192 @default.
• W1968652295 hasBestOaLocation W19686522951 @default.
• W1968652295 hasConcept C126322002 @default.
• W1968652295 hasConcept C141071460 @default.
• W1968652295 hasConcept C187212893 @default.
• W1968652295 hasConcept C2779134260 @default.
• W1968652295 hasConcept C2779316324 @default.
• W1968652295 hasConcept C2780345856 @default.
• W1968652295 hasConcept C71924100 @default.
• W1968652295 hasConceptScore W1968652295C126322002 @default.
• W1968652295 hasConceptScore W1968652295C141071460 @default.
• W1968652295 hasConceptScore W1968652295C187212893 @default.
• W1968652295 hasConceptScore W1968652295C2779134260 @default.
• W1968652295 hasConceptScore W1968652295C2779316324 @default.
• W1968652295 hasConceptScore W1968652295C2780345856 @default.
• W1968652295 hasConceptScore W1968652295C71924100 @default.
• W1968652295 hasIssue "1" @default.
• W1968652295 hasLocation W19686522951 @default.
• W1968652295 hasLocation W19686522952 @default.
• W1968652295 hasOpenAccess W1968652295 @default.
• W1968652295 hasPrimaryLocation W19686522951 @default.
• W1968652295 hasRelatedWork W113810927 @default.
• W1968652295 hasRelatedWork W1586374228 @default.
• W1968652295 hasRelatedWork W2003938723 @default.
• W1968652295 hasRelatedWork W2047967234 @default.
• W1968652295 hasRelatedWork W2118496982 @default.
• W1968652295 hasRelatedWork W2364998975 @default.
• W1968652295 hasRelatedWork W2369162477 @default.

• next